Vax-Before-Travel
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Appointments
Destinations
News
Outbreaks
Vaccines
Anktiva N-803 plus BCG Vaccine Therapy
Anktiva N-803 plus BCG Vaccine Therapy
Fact checked by
Robert Carlson, MD
Apr 23
3 min read
US FDA Approves IL-15 Superagonist for Treating Bladder Cancer
ImmunityBio Anktiva N-803 Plus BCG vaccination is an FDA approved bladder cancer therapy
Bladder Cancer
